17-OH Progesterone Test in Karachi at Dr. Essa Lab

17-OH Progesterone at Dr. Essa Lab

The 17-OH Progesterone (17-Hydroxyprogesterone) test is a highly specialized endocrine investigation used to measure the concentration of a key steroid hormone precursor in the blood. Produced primarily by the adrenal cortex and to a lesser extent by the gonads, 17-OH Progesterone is an essential building block in the biochemical pathway that synthesizes cortisol, the body’s primary stress hormone. When the enzyme responsible for converting 17-OH Progesterone into cortisol is deficient or entirely absent, this precursor hormone accumulates in the bloodstream. This physiological backup is the hallmark of Congenital Adrenal Hyperplasia (CAH), a group of inherited genetic disorders that can have profound implications for growth, development, and metabolic stability. At Dr. Essa Lab, we utilize advanced chemiluminescence immunoassay (CLIA) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) technologies to deliver highly precise and clinically reliable measurements of this critical biomarker.

The clinical importance of evaluating 17-OH Progesterone levels cannot be overstated. It serves as the primary screening tool for newborns suspected of having classic CAH, a life-threatening condition characterized by severe salt-wasting crises, dehydration, and ambiguous genitalia in female infants. Beyond neonatal screening, this assay is invaluable for diagnosing non-classic (late-onset) CAH in adolescent and adult females who present with symptoms mimicking Polycystic Ovary Syndrome (PCOS), such as severe acne, hirsutism, and irregular menstrual cycles. By measuring the exact concentration of 17-OH Progesterone, endocrinologists, pediatricians, and gynecologists can accurately pinpoint enzyme deficiencies, initiate timely hormone replacement therapies, and monitor the efficacy of ongoing treatment regimens. Dr. Essa Lab is committed to providing the highest standard of diagnostic accuracy, ensuring that patients across Karachi and beyond receive timely, actionable insights into their endocrine health.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure the clinical validity of the 17-OH Progesterone test, as hormone levels fluctuate naturally due to diurnal rhythms and menstrual cycles. Patients must adhere to the following preparation guidelines:

• Diurnal Variation Considerations: Because 17-OH Progesterone levels peak in the early morning hours, it is highly recommended that the blood sample be collected between 7:00 AM and 9:00 AM.
• Menstrual Cycle Timing: For adult and adolescent females, the test should ideally be performed during the early follicular phase of the menstrual cycle (typically days 2 to 5 of menstruation), unless otherwise directed by the referring physician.
• Fasting Requirements: While strict fasting is generally not mandatory for a standalone 17-OH Progesterone test, a fasting period of 8 to 12 hours is recommended if other metabolic or lipid panels are being performed concurrently.
• Medication Disclosure: Patients must inform the laboratory staff and their physician of all medications they are currently taking, particularly oral contraceptives, glucocorticoids, progesterone supplements, or other hormonal therapies, as these can significantly alter test results.
• Stress Reduction: Physical and emotional stress can stimulate the adrenal glands and cause transient elevations in hormone levels. Patients should rest quietly for 10 to 15 minutes prior to sample collection.

During the Procedure

The 17-OH Progesterone test is a standard venipuncture procedure performed by our highly trained phlebotomists at Dr. Essa Lab. The process is quick, safe, and designed to minimize patient discomfort:

• Patient Positioning: The patient is asked to sit comfortably in a specialized phlebotomy chair or lie down if they have a history of dizziness during blood draws.
• Site Selection and Preparation: The phlebotomist identifies a suitable vein, typically in the antecubital fossa (the crook of the elbow). The skin over the selected vein is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry to prevent specimen contamination.
• Sample Collection: A sterile, single-use needle is gently inserted into the vein. The blood is drawn into a gold-top serum separator tube (SST) or a red-top clot activator tube. The tourniquet is released as soon as blood flow is established to prevent hemoconcentration.
• Post-Collection Care: Once the required volume of blood is collected, the needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad. A small adhesive bandage is applied to protect the site.
• Duration and Safety: The entire blood collection process takes less than five minutes. Our strict adherence to international biosafety standards and infection control protocols ensures a completely sterile and safe environment for every patient.

When is a 17-OH Progesterone Performed?

Screening for Congenital Adrenal Hyperplasia (CAH) in Newborns

The 17-OH Progesterone test is routinely performed as part of newborn screening programs or when an infant exhibits signs of classic CAH shortly after birth. In female newborns, a deficiency in the 21-hydroxylase enzyme leads to an excess of adrenal androgens, resulting in ambiguous genitalia (virilization). In male infants, the physical signs may not be immediately apparent at birth, but they can rapidly develop severe, life-threatening salt-wasting crises characterized by vomiting, dehydration, hyponatremia, hyperkalemia, and shock within the first few weeks of life. Early detection through this assay allows for immediate life-saving glucocorticoid and mineralocorticoid replacement therapy.

Evaluating Hirsutism and Virilization in Females

Physicians frequently order a 17-OH Progesterone test for adolescent girls and adult women who present with symptoms of androgen excess, also known as virilization. These symptoms include hirsutism (excessive, male-pattern hair growth on the face, chest, and back), severe and treatment-resistant acne, male-pattern baldness (androgenic alopecia), and deepening of the voice. Measuring 17-OH Progesterone helps clinicians differentiate between Polycystic Ovary Syndrome (PCOS), androgen-secreting ovarian or adrenal tumors, and non-classic (late-onset) Congenital Adrenal Hyperplasia, which requires a distinct therapeutic approach.

Investigating Unexplained Infertility and Menstrual Irregularities

Unexplained infertility, oligomenorrhea (infrequent menstrual periods), or amenorrhea (the complete absence of menstruation) are common clinical indications for this test. Non-classic CAH can disrupt the delicate hypothalamic-pituitary-ovarian axis, leading to chronic anovulation and reproductive challenges. By evaluating 17-OH Progesterone levels alongside other reproductive hormones like LH, FSH, and testosterone, reproductive endocrinologists can identify underlying adrenal enzyme deficiencies that may be hindering successful conception and normal menstrual cycling.

Monitoring CAH Treatment Efficacy

For pediatric and adult patients who have already been diagnosed with Congenital Adrenal Hyperplasia, the 17-OH Progesterone test is used as a critical monitoring tool. Regular testing allows endocrinologists to assess whether the dosage of glucocorticoid replacement therapy (such as hydrocortisone, prednisone, or dexamethasone) is adequate. The therapeutic goal is to suppress the overproduction of 17-OH Progesterone and adrenal androgens without causing the adverse effects associated with glucocorticoid excess, such as growth suppression in children or Cushingoid features.

Assessing Adrenal Tumors or Enzyme Deficiencies

In rare clinical scenarios, adult patients presenting with symptoms of adrenal dysfunction, adrenal incidentalomas (unexpected masses found during abdominal imaging), or suspected enzyme deficiencies other than 21-hydroxylase may require a 17-OH Progesterone test. The assay helps map the steroidogenic pathway to determine if an adrenal mass is biochemically active or if there is a partial block in adrenal steroidogenesis. This comprehensive hormonal profiling is essential for formulating an accurate diagnosis and planning appropriate surgical or medical interventions.

What Does a 17-OH Progesterone Detect?

The 17-OH Progesterone test is a powerful diagnostic tool that can detect a wide range of endocrine disorders, physiological states, and therapeutic outcomes. Specifically, this assay is capable of detecting:

• Classic 21-hydroxylase deficiency (salt-wasting form) in critically ill newborns.
• Classic 21-hydroxylase deficiency (simple virilizing form) in infants and young children.
• Non-classic (late-onset) Congenital Adrenal Hyperplasia in adolescents and adults.
• Partial 21-hydroxylase enzyme impairment in heterozygous genetic carriers.
• Adrenal cortical carcinomas that hypersecrete steroid hormone precursors.
• Benign adrenal adenomas producing elevated levels of progesterone intermediates.
• Ovarian tumors or luteomas that contribute to systemic androgen and precursor elevation.
• Polycystic Ovary Syndrome (PCOS) associated with mild adrenal androgen excess.
• Inadequate glucocorticoid replacement therapy in patients with known CAH.
• Overtreatment with glucocorticoids, indicated by excessively suppressed 17-OH Progesterone levels.
• Normal physiological elevations of 17-OH Progesterone during the luteal phase of the menstrual cycle.
• Normal, transient elevations of 17-OH Progesterone in healthy newborn infants during the first 48 hours of life.
• Marked elevations in premature or low-birth-weight infants due to immature adrenal enzyme systems.
• Physiological hormonal surges occurring during normal pregnancy.
• Enzymatic blocks associated with 11-beta-hydroxylase deficiency (which may show cross-reactive elevations).
• Adrenal insufficiency states when evaluated in conjunction with ACTH stimulation testing.
• Hypopituitarism leading to secondary adrenal insufficiency (characterized by low baseline levels).
• The biochemical cause of precocious (early) puberty in young children.
• The underlying endocrine driver of severe, cystic acne in post-pubertal patients.
• Adrenal source of virilization in postmenopausal women.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for diagnostic test results can be a source of anxiety for patients and their families. Because the 17-OH Progesterone test requires highly specialized analytical techniques to ensure maximum accuracy, the standard turnaround time is typically 24 to 48 hours from the time of sample collection. Our laboratory operates under strict internal and external quality control protocols to verify every result before it is released.

Patients can easily access their diagnostic reports through multiple convenient channels. Once the report is finalized and signed off by our consultant pathologist, an automated SMS notification containing a secure download link is sent to the patient’s registered mobile number. Reports can also be accessed and downloaded directly from the official Dr. Essa Lab website by entering the patient’s lab ID and password. For those who prefer physical copies, reports can be collected at any of our conveniently located collection centers across Karachi.

17-OH Progesterone Findings Overview

The interpretation of 17-OH Progesterone levels is highly dependent on the patient’s age, biological sex, developmental stage, and, for females, the specific phase of the menstrual cycle. The table below outlines the general reference ranges and clinical implications of various findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Newborns (Term, >3 days old)	Less than 2.0 ng/mL (Reference ranges may vary slightly by birth weight)	Significantly elevated levels (>10.0 ng/mL) suggest classic 21-hydroxylase deficiency (CAH).
Premature Infants	Slightly higher baseline levels due to adrenal immaturity (up to 5.0 ng/mL)	Extremely high levels require serial monitoring to differentiate immaturity from true CAH.
Adult Males	0.3 to 2.2 ng/mL	Elevated levels may indicate late-onset CAH or an active adrenal tumor.
Adult Females (Follicular Phase)	0.1 to 0.8 ng/mL	Elevations above 2.0 ng/mL warrant further evaluation for non-classic CAH.
Adult Females (Luteal Phase)	0.6 to 2.3 ng/mL (Physiological rise due to corpus luteum activity)	Levels exceeding 10.0 ng/mL outside of pregnancy suggest adrenal hyperplasia or tumor.
Postmenopausal Females	Less than 0.5 ng/mL	Elevated levels indicate potential adrenal pathology or late-onset enzyme deficiency.
ACTH Stimulation Test (Post-Stimulation)	Less than 3.0 ng/mL in healthy individuals	Levels exceeding 10.0 ng/mL confirm non-classic CAH; classic CAH shows much higher surges.
CAH Patients on Treatment	Maintained within a target therapeutic range (typically 1.0 to 5.0 ng/mL)	Very low levels suggest over-suppression; very high levels indicate under-treatment or non-compliance.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for 17-OH Progesterone?

• Experienced healthcare professionals: Our team consists of highly qualified pathologists, biochemists, and laboratory technologists specializing in complex endocrine assays.
• Patient-focused care: We prioritize patient comfort, safety, and confidentiality at every stage of the diagnostic journey.
• Quality diagnostic services: Dr. Essa Lab adheres to rigorous international quality control standards, participating in reputable external quality assurance programs.
• Professional reporting: Our reports are comprehensive, easy to read, and structured to provide clear, actionable insights for referring physicians.
• Modern diagnostic approach: We utilize state-of-the-art automated immunoassay platforms and advanced diagnostic technologies to ensure maximum precision.
• Comfortable environment: Our collection centers are designed to provide a clean, welcoming, and stress-free environment for patients of all ages.
• Convenient location: With an extensive network of branches across Karachi, patients can easily access our services close to home.
• Commitment to accurate diagnosis: We are dedicated to delivering timely and highly accurate results to support early intervention and effective disease management.